Green Cross Health
Market Cap
NZ$138.9m
Last Updated
2019/10/21 10:35 UTC
Data Sources
Company Financials
Executive Summary
Green Cross Health Limited provides health support, care, and advice services to communities in New Zealand.
Snowflake
Fundamentals
Undervalued with adequate balance sheet.
Share Price & News
How has Green Cross Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
-5.0%
GXH
0.2%
NZ Consumer Retailing
1.1%
NZ Market
1 Year Return
-28.4%
GXH
12.1%
NZ Consumer Retailing
19.1%
NZ Market
Return vs Industry: GXH underperformed the NZ Consumer Retailing industry which returned 12.1% over the past year.
Return vs Market: GXH underperformed the NZ Market which returned 19.1% over the past year.
Shareholder returns
| GXH | Industry | Market | |
|---|---|---|---|
| 7 Day | -5.0% | 0.2% | 1.1% |
| 30 Day | -12.7% | 0.4% | 2.7% |
| 90 Day | -17.9% | 4.2% | 1.9% |
| 1 Year | -23.2%-28.4% | 15.1%12.1% | 24.3%19.1% |
| 3 Year | -58.5%-64.4% | 35.3%25.4% | 55.8%35.5% |
| 5 Year | -28.3%-46.7% | 53.6%35.3% | 101.8%56.4% |
Price Volatility Vs. Market
How volatile is Green Cross Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall St
Green Cross Health Limited (NZSE:GXH): The Best Of Both Worlds4 weeks ago | Simply Wall St
If You Had Bought Green Cross Health (NZSE:GXH) Stock Three Years Ago, You'd Be Sitting On A 60% Loss, Today1 month ago | Simply Wall St
Here's What Green Cross Health Limited's (NZSE:GXH) P/E Ratio Is Telling UsValuation
Is Green Cross Health undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: GXH (NZ$0.96) is trading below our estimate of fair value (NZ$2.37)
Significantly Below Fair Value: GXH is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: GXH is good value based on its PE Ratio (8.5x) compared to the Consumer Retailing industry average (20.9x).
PE vs Market: GXH is good value based on its PE Ratio (8.5x) compared to the NZ market (18.7x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate GXH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: GXH is good value based on its PB Ratio (1.1x) compared to the XX Consumer Retailing industry average (1.6x).
Next Steps
Future Growth
How is Green Cross Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
9.5%
Forecasted Consumer Retailing industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Green Cross Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Examine whether Green Cross Health is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Green Cross Health competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Consumer Retailing industry.
Past Performance
How has Green Cross Health performed over the past 5 years?
2.5%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: GXH's earnings have grown by 2.5% per year over the past 5 years.
Accelerating Growth: GXH's earnings growth over the past year (3.2%) exceeds its 5-year average (2.5% per year).
Earnings vs Industry: GXH earnings growth over the past year (3.2%) underperformed the Consumer Retailing industry 3.4%.
Return on Equity
High ROE: GXH's Return on Equity (15%) is considered low.
Return on Assets
ROA vs Industry: GXH has a higher Return on Assets than the Consumer Retailing industry average last year.
Return on Capital Employed
ROCE Improving: GXH's Return on Capital Employed has declined over the past 3 years.
Next Steps
Financial Health
How is Green Cross Health's financial position?
Financial Position Analysis
Short Term Liabilities: GXH's short term assets (NZ$85.5M) do not cover its short term liabilities (NZ$107.3M)
Long Term Liabilities: GXH's short term assets (85.5M) exceeds its long term liabilities (23.6M)
Debt to Equity History and Analysis
Debt Level: GXH's debt to equity ratio (36.7%) is considered satisfactory
Reducing Debt: GXH's debt to equity ratio has increased from 10.4% to 36.7% over the past 5 years.
Debt Coverage: GXH's debt is well covered by operating cash flow (60%).
Interest Coverage: GXH's interest payments on its debt are well covered by EBIT (14.7x coverage).
Balance Sheet
Inventory Level: GXH has a high level of physical assets or inventory.
Debt Coverage by Assets: GXH's debt is covered by short term assets (assets are 1.741320x debt).
Next Steps
Dividend
What is Green Cross Health's current dividend yield, its reliability and sustainability?
7.29%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: GXH's dividend (7.29%) is higher than the bottom 25% of dividend payers in the NZ market (3%).
High Dividend: GXH's dividend (7.29%) is in the top 25% of dividend payers in the NZ market (5.56%)
Stable Dividend: GXH has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: GXH's dividend payments have increased, but the company has only paid a dividend for 9 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (62.2%), GXH's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
Next Steps
Management
What is the CEO of Green Cross Health's salary, the management and board of directors tenure and is there insider trading?
1.6yrs
Average management tenure
CEO
Rachael Newfield 0
0.8yrs
Tenure
Ms. Rachael Newfield has been the Group Chief Executive Officer of Green Cross Health Limited since January 2019.
Management Age and Tenure
1.6yrs
Average Tenure
Experienced Management: GXH's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Age and Tenure
4.8yrs
Average Tenure
Experienced Board: GXH's board of directors are considered experienced (4.8 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Management Team
Jim Greenwood
Company Secretary
- Tenure: 0yrs
Grant Bai
Chief Executive Officer of Pharmacy & Medical
- Tenure: 6yrs
Alison Van Wyk
Chief Executive Officer of Community Health Division
- Tenure: 0yrs
Steve Browning
COO & CFO
- Tenure: 0yrs
Mark Smith
Chief Information Officer
- Tenure: 1.6yrs
Rachael Newfield
Group Chief Executive Officer
- Tenure: 0.8yrs
Board Members
Peter Merton
Chairman
- Tenure: 0yrs
- Compensation: NZ$85.00k
Tony Edwards
Independent Director
- Tenure: 4.2yrs
- Compensation: NZ$60.00k
John Bolland
Non-Executive Director
- Tenure: 11yrs
- Compensation: NZ$35.00k
John Bagnall
Non-Executive Director
- Tenure: 12.2yrs
- Compensation: NZ$35.00k
Ken Orr
Independent Director
- Tenure: 7.6yrs
- Compensation: NZ$65.00k
Peter Williams
Non-Executive Director
- Tenure: 2.4yrs
- Compensation: NZ$35.00k
Carolyn Steele
Independent Director
- Tenure: 2.3yrs
- Compensation: NZ$70.00k
M. Millard
Independent Director
- Tenure: 4.8yrs
- Compensation: NZ$60.00k
Company Information
Green Cross Health Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Green Cross Health Limited
- Ticker: GXH
- Exchange: NZSE
- Founded: 1999
- Industry: Drug Retail
- Sector: Consumer Retailing
- Market Cap: NZ$138.858m
- Shares outstanding: 143.15m
- Website: https://www.greencrosshealth.co.nz
Number of Employees
Location
- Green Cross Health Limited
- Building B
- Ground Floor
- Auckland
- 1051
- New Zealand
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| GXH | NZSE (New Zealand Stock Exchange) | Yes | Ordinary Shares | NZ | NZD | Oct 2009 |
| PRCX.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Oct 2009 |
Biography
Green Cross Health Limited provides health support, care, and advice services to communities in New Zealand. It operates in three segments: Pharmacy Services, Medical Services, and Community Health. The Ph ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/21 10:35 |
| End of Day Share Price | 2019/10/18 00:00 |
| Earnings | 2019/03/31 |
| Annual Earnings | 2019/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.